2nd Wnt And B-Catenin Pathway Targeted Drug Development Summit
By
Hanson Wade
2 Followers
Follow
Event Details
2nd Wnt And B-Catenin Pathway Targeted Drug Development Summit
With an improved understanding of biology and mechanisms of action, the Wnt/B-Catenin community is surging through clinic in 2022 with positive clinical updates. The excitement of a potential first-in-class candidate to advent combination, immuno-oncology therapies in colorectal, head and neck and non-small cell lung cancer is offering hope for patients with high unmet medical needs.
After 2 decades of research, it is now the time for drug developers to act and get together at the 2nd Wnt/B-Catenin Pathway Targeted Drug Development Summit. As the one and only industry-led meeting, you will be equipped with unparalleled insights in:
- Wnt/B-Catenin's structural biology and medicinal chemistry - turning the undruggable druggable
- Comparison of different Wnt/B-Catenin modulation approaches, its interaction with TIL and tumor microenvironment for targeted, combination therapies
- Translating basic science into clinical design - from scheduling to dosing, overcoming toxicity to widen the therapeutic window with safety in mind
- Validating a clinical biomarker for patient selection
In collaboration with Wnt/B-Catenin pioneers such as Iterion Therapeutics, Leap Therapeutics, FogPharma, this is your unique opportunity to join and meet 60+ drug developers to forge long-term collaboration and advance Wnt/B-Catenin as a valuable target and clinical asset, propelling to provide first-in-class treatments for patients!
URLs:
Tickets: https://go.evvnt.com/1364056-0?pid=10018
Inquiries: https://go.evvnt.com/1364056-2?pid=10018
Prices:
Academic Admission: USD 2599.00,
Drug Developer: USD 2999.00,
Service Provider: USD 3599.00
After 2 decades of research, it is now the time for drug developers to act and get together at the 2nd Wnt/B-Catenin Pathway Targeted Drug Development Summit. As the one and only industry-led meeting, you will be equipped with unparalleled insights in:
- Wnt/B-Catenin's structural biology and medicinal chemistry - turning the undruggable druggable
- Comparison of different Wnt/B-Catenin modulation approaches, its interaction with TIL and tumor microenvironment for targeted, combination therapies
- Translating basic science into clinical design - from scheduling to dosing, overcoming toxicity to widen the therapeutic window with safety in mind
- Validating a clinical biomarker for patient selection
In collaboration with Wnt/B-Catenin pioneers such as Iterion Therapeutics, Leap Therapeutics, FogPharma, this is your unique opportunity to join and meet 60+ drug developers to forge long-term collaboration and advance Wnt/B-Catenin as a valuable target and clinical asset, propelling to provide first-in-class treatments for patients!
URLs:
Tickets: https://go.evvnt.com/1364056-0?pid=10018
Inquiries: https://go.evvnt.com/1364056-2?pid=10018
Prices:
Academic Admission: USD 2599.00,
Drug Developer: USD 2999.00,
Service Provider: USD 3599.00
Entry Fees
Free Registration
Categories
Event Frequency
One Time
Event Timings
(GMT-5:00) Central Time (US and Canada)
10:00 AM - 03:00 PM (Jan 24, Jan 25, Jan 26) (General)
Organizer
Hanson Wade
2 Followers
Follow
Hanson Wade specialises in bringing people together through outstanding business conferences and year round community contact.
More Events By Hanson Wade
Comments on 2nd Wnt And B-Catenin Pathway Targeted Drug Development Summit
You must Login to write a comment.
Peoples Interested in Visit
0 Peoples Interested to Visit
Event Location
Hilton Boston Logan Airport
One Hotel Drive ,
Boston 02128, Massachusetts, United States
Boston 02128, Massachusetts, United States
Official Link :